The Sachs 7th Annual Immuno-Oncology innovation forum for business development, licensing and investment will take place from 18th to 20th May as a digital conference.
The programme will be spread across 3 days bringing together leaders from pharma and biotech as well as cancer research institutes, patient advocacy groups and late stage investors.
The event brings together over 300 delegates with more than 25 company presentations. Over half of the attendees are corporate and financial investors, buy-side and sell-side analysts, bankers, legal and business advisors.
Our Business Development team is looking forward to meeting with partners who are interested to find out more about our work. We are available to schedule a meeting at your convenience at the Partnering Lounge during the conference or via email at BD@nanobiotix.com.
Management from Nanobiotix will speak at the following sessions:
The European Society for Medical Oncology (ESMO) Annual Meeting will be virtual this year from 18th to 22nd September. This conference is the opportunity for medical oncologists and other oncology professionals from the many related fields to come together. Pr. Le Tourneau and Pr. De Baere will be there presenting datas.
